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Abstract
Background: There is universal awareness of the difficulties faced by doctors when prescribing antimicrobials.
Methods: Over a six-month period patients hospitalized in the ICU and under treatment with antibiotics and/or
antifungals were eligible to participate in the study. The data were assessed by two infectious diseases specialists.
Once completed, all case forms were sent independently to both evaluators (TZSC and ARM) by e-mail. Based on
the data received, the evaluator completed a form automatically generated on the e-mail and returned it to the
original mailbox for further analysis. We assessed the level of agreement between infectious disease specialists
and the physicians directly responsible for the decision to begin antimicrobial therapy, as well as to assess the
appropriateness of the regimen prescribed.
Results: Among the antimicrobial regimens prescribed to the 177 patients, 36 % were considered inappropriate by
specialist #1 and 38 % were considered inappropriate by specialist #2. We found 78 % agreement by at least one of
the infectious disease specialists with the prescribed antimicrobial regimen, and in 49 % of cases both specialists
agreed with the prescribed regimen. Both disagreed with the prescribed regimen in 22 % of the cases and they
disagreed between themselves in 29 % of the cases.
Conclusion: This study highlights the difficulties in prescribing effective empirical antimicrobial therapy - they are
of such magnitude that even two specialists in infectious diseases, well acquainted with our hospital’s resistance
patterns and our patients’ profiles have considerable disagreement.
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Background
Infections are a major risk factor for unfavorable clinical
outcomes, particularly in the critical care setting [1–5],
where the majority of patients receive antimicrobial
therapy [1, 2]. Appropriate antimicrobial therapy may
help reduce mortality in critically ill patients, and each
hour of delay in the administration of the appropriate
antimicrobial agent is associated with a 7.6 % increase in
mortality [6–9]. Therefore, empiric broad-spectrum anti-
microbial coverage is recommended in the more severe
cases, particularly when multidrug-resistant microorgan-
isms are suspected [1, 6, 7, 10].
While antimicrobial drugs have changed the prognosis
of such patients, their excessive and indiscriminate use
has led to the development of resistant microorganisms,
infection with Clostridium difficile, and other adverse
events [1, 3, 6, 11–18].
Several factors allow for widespread use of antimicro-
bial agents even when inappropriate. A major factor is
unrestricted availability to antimicrobials [12, 13], com-
bined with social, cultural and behavioral factors, and
certain institutional policies [13]. Also, broad-spectrum
empirical therapy is common, even when clinical signs
of infection are absent [19].
In order to limit antimicrobial-induced selective pres-
sure, especially that resulting from the use of broad-
* Correspondence: alexandre.marra@einstein.br
2Division of Medical Practice, Hospital Israelita Albert Einstein, Av. Albert
Einstein, 627/701 – 1st floor – Bloco A1 – Room 108 Morumbi, 05651-901
São Paulo, Brazil
Full list of author information is available at the end of the article
© 2015 Casaroto et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Casaroto et al. BMC Infectious Diseases  (2015) 15:248 
DOI 10.1186/s12879-015-0992-y
spectrum antibiotics [4, 6, 10, 17], a de-escalation ap-
proach (a change in antibiotic therapy to a narrower
spectrum regimen compared to the initial antibiotic pre-
scription) has been encouraged; however, it is not a
commonly performed medical practice [1, 6, 7, 10, 18].
The objective of this study was to assess the level of
agreement between infectious disease specialists and the
physicians directly responsible for the decision to begin
antimicrobial therapy, as well as to assess the appropri-
ateness of the regimen prescribed.
Methods
The study was conducted in the medical-surgical Intensive
Care Unit (ICU) of Hospital Israelita Albert Einstein, in
São Paulo, SP, Brazil, from June 2010 through December
2011. All 40 ICU beds were included, most of them occu-
pied by private patients; a small percentage of these beds
are reserved for patients from the public healthcare
network, usually those receiving transplants. The ICU
operates with an open staffing model, and the prescription
of antimicrobials, as well as other medical decisions, gen-
erally reflects the interactions between the specialists in-
volved in each case and the ICU staff physicians, rather
than being the sole responsibility of the primary team.
However, ultimate decisions are made by the primary phy-
sicians responsible for the patient (not the ICU physician
that also participates in the care of the patient).
This was a prospective, observational study approved
by the IRB of Hospital Israelita Albert Einstein. The re-
quirements for informed consent were waived by our
IRB in accordance of the Code of Federal Regulation
and of the Privacy Rule. Epidemiologic and laboratory
data were captured on a case report form (CRF); the col-
lected information was considered sufficient by the study
team to assess the prescription of antimicrobials in the
hospital’s ICU.
Patients hospitalized in the ICU and under treatment
with antibiotics and/or antifungals were eligible to par-
ticipate in the study, provided they met the following
criteria: CRFs were completed within 72 h of the anti-
microbial introduction; age > 18 years; antimicrobial pre-
scription occurred after patient’s admission to the ICU.
Patients admitted to any other hospital ward were eli-
gible to participate if the antimicrobial had been pre-
scribed immediately before the patient’s transfer to the
ICU. The exclusion criteria were: patients receiving
antimicrobial prophylaxis post-operatively and/or due to
immunosuppression; >72 h elapsed from the start of anti-
microbial therapy; antimicrobials were prescribed outside
the ICU, except in those cases described above; and the
early postoperative period following organ transplantation.
Data on “recent hospital admission” (within past
3 months) and “prior use of antibiotic therapy” (past
15 days) were obtained from patients, family members,
caregivers and/or verified in the patient’s medical re-
cords. After the time of admission, all information was
obtained exclusively from the patient’s medical records.
Two different procedures for data collection were
adopted. For newly admitted patients, if the antimicro-
bial was prescribed at admission, data were obtained ex-
clusively from the hospital admission forms (physician
and nurse), and subsequent lab data were disregarded; if
the antimicrobial was introduced after laboratory data
were available, the admission forms and the lab report
were collected. For patients already hospitalized and who
had their antimicrobial regimen newly prescribed and/or
changed according to the above mentioned criteria, data
were collected from the 24-h period prior to the introduc-
tion/change in the regimen; for the purposes of analysis,
the most extreme laboratory data were considered.
Organ dysfunctions were diagnosed based on the follow-
ing measurements: cardiovascular dysfunction: systolic BP
<90 mmHg or mean BP <65 mm Hg or use of vasopres-
sors (noradrenaline, dopamine, epinephrine, vasopressin);
hematologic disorders: platelets <100,000; liver dysfunc-
tion: total bilirubin >2.0 mg/dL; neurological disturbance:
drowsiness, confusion, agitation or coma; renal disorders:
creatinine >2.0 mg/dL or urine output <0.5 mL/kg/h over
the previous 6 h or indication for hemodialysis (except
chronic maintenance dialysis); respiratory dysfunction:
O2 saturation <90 % with or without O2 supplementation
or pO2/FiO2 < 200. Tissue hypoperfusion was quantita-
tively measured by serum levels of arterial lactate [7, 20].
Previous antibiotic treatment was defined as an anti-
biotic prescribed for at least 48 h during the fifteen-day
period prior to the onset of the current antimicrobial
therapy [20].
Patients undergoing long-term steroid therapy, chemo-
therapy and/or radiation therapy, immunosuppressant
therapy due to organ transplantation, and those with neo-
plasms were considered to be immune compromised.
Patients were considered institutionalized if they
had been transferred from nursing homes or equiva-
lent facilities.
Specialists’ opinion
The data were assessed by two infectious diseases
specialists with 10- and 17-years experience in the field,
both holding master degrees and one of them also a PhD.
Both have been members of the hospital’s Nosocomial
Infections Control Commission and have a solid reputa-
tion in their field; additionally they are routinely involved
in the care of critically ill patients admitted to the ICU.
Once completed, all case forms were sent independ-
ently to both evaluators (TZSC and ARM) by e-mail.
Based on the data received, the evaluator completed a
form automatically generated on the e-mail and returned
it to the original mailbox for further analysis. On this
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form, the specialist was required to say if he agreed or
disagreed with the prescribed antimicrobial regimen. If
he said “no”, he was instructed to justify his disagree-
ment; for example, the regimen was broader than neces-
sary, at least one class of antimicrobial was unnecessary,
the regimen was narrower than necessary, or there was
no indication for an antimicrobial agent.
Statistical analysis
This is a descriptive study; the only statistical test ap-
plied was the chi-square test, at the significance level of
p = 0.05. Statistical analyses were done using the Statis-
tical Package for the Social Sciences software (SPSS,
Chicago, IL, U.S.A.). For all other tabulations we used
Microsoft Excel.
Results
In this study, 177 patients were assessed (100 [56.5 %]
males and 77 [43.5 %] females). Sixty one percent of the
patients were older than 60 years (65.09 ± 20.35). Thirty-
five percent were immune compromised, mostly due to
transplantation and/or steroid therapy. Most patients
(62.1 %) had a prior history of antimicrobial therapy at
the time of data collection and approximately one third
had a previous recent hospital admission. There was evi-
dence of at least one organ dysfunction in 78 % of the
patients, confirming the severity of these cases. Table 1
shows the data obtained.
We found 78 % agreement by at least one of the infec-
tious disease specialists with the prescribed antimicrobial
regimen, and in 49 % of cases both specialists agreed with
the prescribed regimen. Both disagreed with the pre-
scribed regimen in 22 % of the cases and they disagreed
between themselves in 29 % of the cases (Table 2).
Among the antimicrobial regimens prescribed to the
177 patients, 36 % were considered inappropriate by spe-
cialist #1 and 38 % were considered inappropriate by
specialist #2, as shown in Table 3. Concerning the rea-
sons for disagreement, nearly one third of the cases were
deemed to have no indication for antimicrobials (27 %
according to specialist #1 vs 33 % according to specialist
#2). Concerning the antibiotic spectrum, the overall per-
centages deemed inappropriate were similar (73 % vs
67 %); however, the reasons for disagreement were
different. Specialist #1 believed that the spectrum of ac-
tivity was broader than necessary in 19 % of the cases,
and in 30 % too narrow. Specialist #2 believed that the
spectrum was too broad in 25 % of cases and too narrow
in 13 %. Antimicrobial therapy was considered unneces-
sary in 22 % and 25 % of cases for specialists 1 and 2, re-
spectively. In a small percentage of cases a broader than
necessary spectrum plus an unnecessary class of drugs
was mentioned (Table 4).
In 52 cases, the specialists disagreed between them-
selves (Table 5); specialist #1 found that the regimen was
inadequate in 24 cases and specialist #2 found it inad-
equate in 28 cases. When we assessed only this sample,
we noticed that the major factor explaining the diverging
opinions was the spectrum - either more broad or more
narrow than necessary; specialist #1 judged 12 cases as
too narrow (50 %) vs 1 case too broad (4 %) while spe-
cialist #2 judged 2 cases as too narrow (7 %) vs 8 as too
broad (29 %), suggesting a more conservative profile of
the latter.
There was less difference of opinion among the spe-
cialists with regards to no indication for antimicrobials
(6 cases (25 %) according to specialist #1 vs. 11 (39 %)
according to specialist #2). The rate of disagreement
with regards to unnecessary class of antimicrobials was
small (5 cases (21 %) according to specialist #1 vs. 7
(25 %) according to specialist #2, Table 5).
When we compared the patients’ characteristics be-
tween the diverging and the converging samples, only
the presence of an indwelling urinary catheter showed a
statistically significant difference (p = 0.043). There was
no difference between specialists on the basis of patient
factors (immunocompromised status, p = 0.93; previous
use of antibiotic, p = 0.66; recent surgery, p = 0.13; and
organ dysfunction, p = 0.08).
In the 52 cases where the specialists disagreed between
themselves, diagnoses were limited to four groups (Table 6):
empiric use (empiric introduction and/or change of the
antimicrobial regimen without initial identification of the
infection site), sepsis, acute respiratory failure (ARF), and
antimicrobial regimen changed after a positive culture was
reported. The antimicrobial spectrum was considered
broader than necessary or the drugs were considered
unnecessary in many cases from the first two groups by
specialist #2 and in most cases from the fourth group ac-
cording to specialist #1. In the ARF group, disagreement
was based mainly on a spectrum deemed broader than ne-
cessary or an unnecessary antimicrobial class. The most
common previously used antimicrobials were glycopep-
tides (36.4 %) and 3rd generation cephalosporins (31.8 %)
(Table 7).
Discussion
We found considerable differences between the special-
ists’ opinions about the prescribed antimicrobial therapy,
with less than half of the prescriptions being judged ap-
propriate by both (Table 2). In general it appears that
specialist #1 has a more aggressive approach to the use
of antimicrobials, while specialist #2 was more conserva-
tive. We could not distinguish a homogeneous pattern
justifying such different approaches; however, when we
analyzed some diagnostic subsets within the sample with
diverging opinions, we noticed that specialist #1 was
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more aggressive with respect to those subgroups where
the patients had sepsis or where the antimicrobial
therapy had been started empirically, and more
conservative when treating the subgroup in which the
introduction or change in antimicrobial therapy had
been motivated by a positive culture, where he consid-
ered the regimen to be broader than necessary or even
unnecessary. It is difficult to understand the reasons for
this divergence. In the analysis of the data, we found no
other characteristics that might clarify this issue or
reveal the nature of the differences in prescription
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Respiratory culture 12 6.8
Urine culture 8 4.5
Blood culture 5 2.8
Other 4 2.2
SIRS – Systemic Inflammatory Response Syndrome
Table 2 Analysis of agreement in antimicrobials prescription
n (354) %
Mutual agreement (both specialists agreed) with
prescribing physician
172 48.6
Agreement by at least one specialist with
prescribing physician
276 78.0
Mutual disagreement (both specialists disagreed) 78 22.0
Disagreement between specialists 104 29.4
Casaroto et al. BMC Infectious Diseases  (2015) 15:248 Page 4 of 7
patterns between the two specialists. The act of prescrib-
ing depends on a series of variables: medical knowledge,
doctors’ and patients’ cultural beliefs, socio-economic
factors, a desire to make independent decisions, expecta-
tions about the outcome, ability to break the inertia of
routine practice and implement recommendations,
medical hierarchy and respect for peers [1, 15]. Factors
like no familiarity with or no awareness of the guidelines
as well as insufficient knowledge about infectious diseases,
potential causative agents and local susceptibility may
contribute negatively at the moment of prescribing these
drugs [1, 13]. Furthermore, there is a prevailing feeling of
safety and comfort with the use of broad-spectrum empir-
ical therapy, irrespective of the guidelines [13]; in addition,
certain doctors overestimate their patients’ expectations
about antimicrobials and tend to prescribe these drugs as
a means of strengthening a good doctor-patient relation-
ship [21], or to maintain collegial relationships between
consultant physicians and the primary service physicians.
In 29 % of the cases the specialists disagreed with each
other, which may be explained by individual professional
characteristics [13, 22], differing choices of empirical
therapy, experience and years of practice, and difficulties of
using more sensitive microbiological methods for diagnosis.
The development of techniques and resources that enable a
faster and more accurate identification of microorganisms
and their susceptibility profile is warranted [14, 17]. The
prior administration of an antimicrobial agent is the most
important risk factor for drug-resistant nosocomial
infections since it predisposes the patient to colonization by
bacteria that are usually resistant to that agent [3, 9, 23]. In
our study, 62.1 % of the patients had prior treatment
with some form of antimicrobial therapy: 20 % received
carbapenems, 36 % glycopeptides and 64.5 % received
combination therapy (Table 7). Some studies indicate that
over one-third of hospitalized patients receive at least one
antimicrobial during hospitalization [15], and among
critically ill patients this rate exceeds 70 % [1, 2].
Some strategies seem to be effective in the fight
against the increase of resistant microorganisms and
the indiscriminate use of antimicrobials. These include
restriction and pre-approval forms that limit the
availability of antimicrobials [6, 12, 13], audits plus
interventions [6, 16], an established prevention policy
with more rational use of these agents, i.e., fewer
antimicrobials and shorter treatment duration [4, 6,
13, 16], microbiological surveillance [11], review of
prescriptions and emphasis on appropriate use by the
Table 3 Inappropriate antimicrobial regimen, per specialist
Specialist #1 Specialist #2
n total n % n %
Inappropriate 177 63 35.6 67 37.9
Table 4 Reasons for assessing antimicrobial therapy as
inappropriate
Specialist #1 Specialist #2
n (63) % n (67) %
Antimicrobial
activity
46 73.0 45 67.2
Spectrum too broad 12 19.0 17 25.4
Spectrum too necessary 19 30.2 9 13.4
Unnecessary
antimicrobial class




1 1.6 2 3.0
No indication for
antimicrobial
17 27.0 22 32.8
Table 5 Reasons for discordance between specialists when
antimicrobial therapy was deemed inappropriate
Specialist #1 Specialist #2
n (24) % n (28) %
Spectrum too narrow 12 50.0 2 7.1
Spectrum too broad 1 4.2 8 28.6
Unnecessary class 5 20.8 7 25.0
No indication for antimicrobial 6 25.0 11 39.3
Table 6 Main diagnosis in the specialists’ divergent sample





Empirical 14 Specialist #1 assessed that in 4
cases the spectrum was too narrow;
specialist #2 considered that in 8
cases there was no indication for
antimicrobials and in 2 cases the
antimicrobial class was unnecessary
Sepsis 9 Specialist #1 assessed that in 4 cases
the spectrum was too narrow;
specialist #2 assessed in 1 case the
spectrum was too narrow, in 3 cases
it was too broad and in 1 case the
antimicrobial class was unnecessary
ARF 6 Specialist #1 assessed that in 1 case
there was no indication for
antimicrobial and in 1 case the
antimicrobial class was unnecessary.
Specialist #2 assessed that in 2 cases
the spectrum was too broad and in
2 cases the antimicrobial class was
unnecessary
Positive culture 7 Specialist #1 assesssed that in 2
cases the spectrum was too narrow,
in 1 case the antimicrobial class was
unnecessary, in 1 case the spectrum
was too broad, and in 3 cases there
was no indication for antimicrobials
ARF acute renal failure
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clinical pharmacist [13, 16], and implementation of an
automated system for prescription of antimicrobials
[4, 22, 23]. Behavioral approaches to optimize the pre-
scription of antimicrobials do not seem to have the
expected result [15, 18], i.e. restrictive interventions
are shown to be more effective than those based solely
on education and orientation [16, 17].
This study has some limitations, namely the fact that
it was a single-center study and data were randomly
collected, i.e., not all patients who met the criteria were
included. Also, due to the method used for inclusion,
some patients with an indication for antimicrobial ther-
apy and who remained untreated were not included in
the sample used to evaluate the agreement with the pre-
scription. Furthermore, the study design is not the best
recommended for this type of assessment, since the spe-
cialists were asked to judge the prescription as appropri-
ate or inappropriate, and the specialist may have been
biased by the decision of the prescribing doctor. An al-
ternative approach would have been to ask the specialist
to examine the patients’ records and prescribe the anti-
microbial regimen without reviewing the drugs that were
actually prescribed. Another difficulty with the study
when comparing the assessment by the two specialists is
the lack of a gold standard. This would have been more
easily accomplished should 100 % of our cultures yielded
a microorganisms and an antibiogram on which to make
a decision (adequate or not adequate antimicrobial ther-
apy). However, there is a low rate of positivity of blood
cultures in this population [24], which leads to diversity
in antimicrobial practices.
While these data may not be entirely generalizable,
they highlight the difficulties in prescribing effective em-
pirical antimicrobial therapy - they are of such magni-
tude that even two specialists in infectious diseases, well
acquainted with our hospital’s resistance patterns and
our patients’ profiles have considerable disagreement.
To minimize such differences we need faster and more
accurate diagnostic tests as well as a better understand-
ing by frontline providers of clinical guidelines and local
susceptibility patterns. Only then can we reach a higher
rate of agreement, and implement rational and appropri-
ate use of antimicrobials. Otherwise, in the future we may
have further selection of resistant microorganisms against
which we scarcely have effective therapeutic resources.
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